Gatralimab
Based on 1 publication(s) in Google Scholar
Gatralimab (GZ-402668) is an IgG1 anti-CD52 monoclonal antibody.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 97.94%
- CAS 番号: 1826020-80-7
- 分子量:145 kDa
-
保管条件:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
CD52
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized CD52 Protein, Human (His, HY-P72123) can bind Gatralimab. The EC50 for this effect is 13.12 ng/mL.
Product Details
-
CAS 番号 1826020-80-7
-
アクセッション番号 P31358
-
別名 GZ-402668
-
分子量 145 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
性状
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
純度
97.94%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
輸送条件
Shipping with dry ice.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
NPJ Breast Cancer
CD52 signaling via macrophage Siglec-G represents a therapeutic target for cancer immunotherapy. [Abstract]2026 Jan 24;12(1):29. PMID: 41580422
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)